WallStSmart

Salesforce.com Inc (CRM)vsHealth In Tech, Inc. Class A Common Stock (HIT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 125556% more annual revenue ($42.83B vs $34.08M). CRM leads profitability with a 18.7% profit margin vs -2.4%. CRM earns a higher WallStSmart Score of 71/100 (B).

CRM

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 7.3Quality: 4.5
Piotroski: 5/9Altman Z: 1.50

HIT

Avoid

29

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 4.29
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+74.7%)

Margin of Safety

+74.7%

Fair Value

$722.63

Current Price

$185.66

$536.97 discount

UndervaluedFair: $722.63Overvalued

Intrinsic value data unavailable for HIT.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM5 strengths · Avg: 8.8/10
EPS GrowthGrowth
52.2%10/10

Earnings expanding 52.2% YoY

Market CapQuality
$164.49B9/10

Large-cap with strong market position

Return on EquityProfitability
23.4%9/10

Every $100 of equity generates 23 in profit

Operating MarginProfitability
21.8%8/10

Strong operational efficiency at 21.8%

Free Cash FlowQuality
$6.56B8/10

Generating 6.6B in free cash flow

HIT2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.2910/10

Safe zone — low bankruptcy risk

Areas to Watch

CRM2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.504/10

Distress zone — elevated risk

Debt/EquityHealth
1.223/10

Elevated debt levels

HIT4 concerns · Avg: 2.5/10
Market CapQuality
$64.69M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-3.7%2/10

ROE of -3.7% — below average capital efficiency

Free Cash FlowQuality
$-3.68M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on EPS Growth, Market Cap, Return on Equity. Profitability is solid with margins at 18.7% and operating margin at 21.8%. Revenue growth of 13.3% demonstrates continued momentum.

Bull Case : HIT

The strongest argument for HIT centers on Debt/Equity, Altman Z-Score.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score, Debt/Equity.

Bear Case : HIT

The primary concerns for HIT are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

CRM profiles as a mature stock while HIT is a turnaround play — different risk/reward profiles.

CRM is growing revenue faster at 13.3% — sustainability is the question.

CRM generates stronger free cash flow (6.6B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (71/100 vs 29/100), backed by strong 18.7% margins and 13.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Health In Tech, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Health In Tech, Inc. (HIT) is a leading innovator in the digital health sector, specializing in technology solutions that enhance healthcare delivery and patient outcomes. Utilizing advanced data analytics and proprietary software, HIT enables healthcare providers and patients to make informed decisions, thereby increasing operational efficiencies. The company’s strong commitment to compliance and cybersecurity positions it favorably within the rapidly growing digital health landscape. As the market continues to evolve, HIT is strategically positioned for growth, aiming to be a pivotal player in the global advancement of technology-driven healthcare solutions.

Want to dig deeper into these stocks?